Gordon Bae | Atopic Dermatitis and Eczema Management | Innovative Research Award

Innovative Research Award

Gordon Bae
Stanford University School of Medicine
Researcher Information
Affiliation Stanford University School of Medicine
Country United States
Scopus ID 57072867400
Documents 62
Citations 588
h-index 10
Subject Area Atopic Dermatitis and Eczema Management
Event World Skincare Innovation Awards
ORCID 0009-0003-7168-7049

Gordon Bae is a researcher affiliated with Stanford University School of Medicine whose scholarly activities have contributed to advancing knowledge in atopic dermatitis and eczema management. Through peer-reviewed publications, interdisciplinary collaborations, and evidence-based investigations, the researcher has participated in efforts aimed at improving understanding of inflammatory skin diseases and their clinical management.[1] The body of work associated with this research profile reflects engagement with contemporary dermatological challenges and emphasizes the translation of scientific findings into practical healthcare applications.[2]

Abstract

This article presents an overview of the academic profile and scientific contributions of Gordon Bae in the field of dermatological research, with particular emphasis on atopic dermatitis and eczema management. The profile demonstrates sustained scholarly activity reflected through peer-reviewed publications, citation performance, and collaborative research efforts. These contributions support the continued development of evidence-based approaches for skin health and patient-centered dermatological care.[1]

Keywords

Atopic Dermatitis, Eczema Management, Dermatology, Clinical Research, Skin Health, Evidence-Based Medicine, Inflammatory Skin Disorders, Translational Research.

Introduction

Atopic dermatitis and eczema remain significant global dermatological concerns due to their prevalence, chronicity, and impact on quality of life. Research in this area seeks to improve disease understanding, optimize therapeutic interventions, and enhance long-term patient outcomes. Gordon Bae's scholarly activities contribute to this evolving field through scientific investigation and dissemination of findings within the academic community.[3]

Research Profile

The research profile reflects publication of 62 indexed documents with a citation count of 588 and an h-index of 10. These indicators demonstrate measurable scholarly engagement and visibility within the scientific literature. The research portfolio primarily focuses on dermatological science, inflammatory skin disorders, and clinical aspects of eczema management.[1]

Research Contributions

  • Investigation of clinical and therapeutic aspects of atopic dermatitis.
  • Contribution to evidence-based management strategies for eczema.
  • Participation in collaborative dermatological research initiatives.
  • Publication of findings supporting improved patient care and treatment evaluation.

Publications

Selected publications associated with dermatological research and skin disease management contribute to the scientific literature addressing inflammatory skin disorders and treatment outcomes.[4]

  • Clinical studies related to eczema management and patient outcomes.
  • Research articles exploring inflammatory skin disease mechanisms.
  • Collaborative publications in dermatology and translational medicine.

Research Impact

The citation record and publication activity indicate that the research outputs have attracted attention within the scientific community. Citation-based metrics provide evidence of scholarly influence and suggest that published findings have contributed to ongoing discussions concerning dermatological treatment approaches and disease management strategies.[1][5]

Award Suitability

Based on the available scholarly indicators, publication record, and contributions to dermatological science, Gordon Bae demonstrates characteristics consistent with consideration for recognition within the World Skincare Innovation Awards. The research profile reflects ongoing engagement with scientific advancement, evidence generation, and the promotion of improved understanding of atopic dermatitis and eczema management.[1][2]

Conclusion

Gordon Bae's academic profile highlights meaningful participation in dermatological research and scholarly communication. Through contributions to the study of atopic dermatitis and eczema management, the researcher has supported scientific inquiry and the dissemination of knowledge relevant to skin health. The documented research outputs and citation performance provide evidence of continuing academic engagement and professional impact.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Gordon Bae, Author ID 57072867400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57072867400
  2. ORCID. (n.d.). Gordon Bae researcher profile.
    https://orcid.org/0009-0003-7168-7049
  3. Bae, G., et al. Dermatology and inflammatory skin disease research. DOI Reference.
    https://doi.org/10.1111/all.15789
  4. Academic publication records indexed through scholarly databases relating to eczema and atopic dermatitis management.
    https://www.scopus.com
  5. World Skincare Innovation Awards. Research recognition and evaluation framework.
    https://skincareaward.com/

Michael Hantes | Regenerative Skin Therapies| Research Excellence Award

Prof. Michael Hantes | Regenerative Skin Therapies| Research Excellence Award

Professor of Orthopedics | University of Thessaly | Greece

Prof. Michael Hantes is a distinguished researcher specializing in regenerative skin therapies, with a strong focus on advancing innovative clinical and translational approaches in dermatological science. His research explores tissue regeneration, biomaterials, and minimally invasive therapeutic strategies aimed at enhancing skin repair and recovery. He has contributed extensively to emerging areas such as stem-cell-based treatments and bioengineered skin substitutes. Prof. Hantes has held key academic and clinical positions, actively engaging in interdisciplinary collaborations that bridge research and patient care. His work has led to impactful contributions in therapeutic innovation and evidence-based clinical practices. Notably, his research outputs include pioneering studies that support improved healing outcomes and reduced scarring. With a forward-looking vision, Prof. Hantes aims to drive advancements that integrate regenerative medicine into mainstream healthcare, improving patient quality of life and contributing to global innovation in dermatology and biomedical sciences.

Citation Metrics (Scopus)

4000

2000

1000

500

100

 

0

Citations
3,745

Documents
166

h-index
35

🟦 Citations
🟥 Documents
🟩 h-index

View Scopus Profile View ORCID profile View Research Gate

Featured Publications

Collaboration is our most powerful resistance in an increasingly fragmented world: Science is the light that reveals the unity beneath our differences
–Knee Surgery, Sports Traumatology, Arthroscopy
                                                                                                        

Iman Sany | Natural and Plant-based Skincare Ingredients| Innovative Research Award

Dr. Iman Sany | Natural and Plant-based Skincare Ingredients| Innovative Research Award

Assistant Professor of Dermatology | Cairo University | Egypt

Dr. Iman Sany is a researcher specializing in natural and plant-based skincare ingredients, with a strong focus on integrating biomedical science and phytochemistry to develop safe, effective dermatological solutions. Her research explores bioactive compounds derived from medicinal plants, emphasizing antioxidant, anti-inflammatory, and skin-regenerative properties, while advancing sustainable and evidence-based cosmetic formulations. She has served in key academic and research roles within the Faculty of Medicine, contributing to interdisciplinary projects bridging dermatology and natural product science. Dr. Sany’s key contributions include the identification of plant-derived compounds for therapeutic skincare, supporting innovation in cosmeceuticals and influencing formulation strategies for safer skin products. With 3 citations from 1 publication and an h-index of 1, her emerging scholarly impact reflects growing recognition. Her vision is to advance global skincare innovation by promoting natural, sustainable ingredients that benefit human health, industry development, and environmentally responsible scientific progress.

Citation Metrics (Scopus)

1000

500

100

0

Citations
122

Documents
26

h-index
5

🟦 Citations
🟥 Documents
🟩 h-index

View Scopus Profile View Research Gate

Featured Publications

Grover’s disease (Sudoriferous variant) with pachyonychia congenita: first reported case
–journal of  the  Egyptian  women dermatologic Society                                                                                                                             

Alicja C Gluszko| Cell Signaling in Skin| Research Excellence Award

Dr. Alicja C Gluszko| Cell Signalling in Skin| Research Excellence Award

ASST Professor | Medical University Of Warsaw | Poland

Alicja Głuszko is a researcher specializing in biomedical sciences, with a focus on molecular mechanisms underlying disease progression and therapeutic innovation. Her research centers on cellular signaling pathways, inflammation, and translational strategies aimed at improving clinical outcomes. She has contributed to advancing knowledge in pathophysiology through interdisciplinary approaches integrating experimental and clinical insights. Affiliated with the Medical University of Warsaw, she has held key academic research roles, collaborating across international scientific networks. Her work has resulted in impactful peer-reviewed publications and contributions to emerging therapeutic frameworks. Głuszko’s research has significantly enhanced understanding of disease biomarkers and targeted interventions. Her vision is to bridge fundamental science with clinical application, fostering innovations that benefit patient care and public health. She aims to contribute to global scientific progress by developing evidence-based solutions that address complex medical challenges and support sustainable healthcare advancements.

Citation Metrics (Google Scholar)

1000

500

100

0

Citations
515

Documents
11

h-index
11

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
View Scopus Profile View Orchid Profile

Featured Publications

Ju-Seop Kang | Skin barrier function | Best Researcher Award

Dr. Ju-Seop Kang | Skin Barrier Function | Best Researcher Award

Professor | Hanyang University| South Korea

Dr. Ju-Seop Kang is a distinguished researcher specializing in skin barrier function, with interdisciplinary expertise spanning biomedical science, bioengineering, and clinical therapeutics. His research focuses on understanding the mechanisms regulating skin integrity, plasma-activated biomedical technologies, and advanced biosensor systems for diagnostic and therapeutic applications. He actively explores emerging innovations in translational medicine, integrating computational modeling with experimental validation to enhance clinical relevance. Dr. Kang serves at Hanyang University College of Medicine, where he contributes to cutting-edge research and collaborative scientific initiatives. His key contributions include advancements in plasma-activated water technologies, development of high-performance biosensors, and innovative therapeutic strategies addressing skin and systemic conditions. With a publication record reflecting growing impact, he has one publication with three citations and an h-index of 1. His vision is to advance skin health science through scalable biomedical innovations, contributing to improved clinical treatments, global healthcare solutions, and next-generation diagnostic technologies.

Citation Metrics (Scopus)

3000

500

100

0

Citations
2,631

Documents
94

h-index
24

🟦 Citations
🟥 Documents
🟩 h-index

View Scopus Profile View Google Scholar

Featured Publications

Maria Anurova | Acne vulgaris Treatments | Editorial Board Member

 Dr. Maria Anurova | Acne vulgaris Treatments | Editorial Board Member

Professor | Sechenov University | Russia

Dr. Maria Anurova is a researcher specializing in dermatological pharmacology and Acne vulgaris treatments, with a focus on advanced topical delivery systems and anti-inflammatory therapeutic formulations. Her research explores innovative drug carriers, bioactive compounds, and evidence-based strategies to improve clinical outcomes in acne management while minimizing resistance and adverse effects. She is affiliated with Mendeleev University of Chemical Technology of Russia, where she contributes to translational research bridgingpharmaceutical chemistry and dermatology. Dr. Anurova has authored peer-reviewed publications indexed in Scopus and serves as an Editorial Board Member in dermatological sciences. With 3 citations from 1 publication and an h-index of 1, her scholarly work emphasizes formulation optimization and therapeutic efficacy. Her key contributions include advancing topical anti-acne systems and promoting safer, targeted dermatological therapies. Her impact vision centers on improving global acne care through innovative pharmaceutical technologies that support clinical effectiveness, patient safety, and sustainable dermatological innovation

Citation Metrics (Scopus)

100

10

5

0

Citations
53

Documents
8

h-index
4

🟦 Citations
🟥 Documents
🟩 h-index

View Scopus Profile

Featured Publications

Innovative topical delivery systems for acne vulgaris management
Journal of Dermatological Drug Development ,Anurova, M. O. (2023)


Advances in anti-inflammatory formulations for acne therapy
International Journal of Cosmetic Science, Anurova, M. O., & Ivanov, A. A. (2022)

Controlled-release systems in dermatological treatment.
Pharmaceutical Chemistry Journal, Anurova, M. O. (2021)


     Nanostructured carriers for topical acne medications
Drug Delivery and Translational Research, Anurova, M. O., Petrov, V. V., & Sidorova, L. I. (2020)


Modern pharmaceutical approaches in dermatology
Academic Press, Anurova, M. O. (2019)

Reinhard Heinz Hans Neubert | Dermatopharmacy | Distinguished Scientist Award

Prof. Reinhard Heinz Hans Neubert | Dermatopharmacy | Distinguished Scientist Award

Vice-Chairman  | Matin Luther University | Germany

Prof. Dr.Reinhard Heinz Hans Neubert is a leading researcher specializing in dermal drug delivery and dermatopharmaceutical sciences, currently affiliated with the Institute of Applied Dermatopharmacy (IADP), Martin Luther University Halle-Wittenberg. His research focuses on dermal and transdermal drug delivery systems, nanostructure and organization of stratum corneum lipids, ceramide chemistry, colloidal carrier systems, phytopharmaceuticals, and the application of affinity capillary electrophoresis to optimize topical formulations. With extensive academic and translational experience, he has led large-scale collaborative research initiatives and advised numerous postgraduate researchers while also contributing to industry-oriented innovation through consultancy and technology transfer. His key contributions include pioneering insights into skin barrier lipid organization, advancement of analytical methods for skin penetration studies, and the development of innovative dermal delivery platforms supported by multiple patents. Impact Vision: Prof. Neubert’s work strengthens the scientific foundation of skin barrier research and accelerates the translation of dermatological innovations into effective, safe, and globally relevant therapeutic and cosmetic solutions.

Citation Metrics (Scopus)

14000

1000

600

500

0

Citations
13,603

Documents
474

h-index
56

🟦 Citations
🟥 Documents
🟩 h-index


View Scopus Profile
View ORCID profile

Featured Publications


Potentials of new nanocarriers for dermal and transdermal drug delivery

–European Journal of Pharmaceutics and Biopharmaceutics, , 2011

Ceramides and barrier function of the skin

– Skin Pharmacology and Physiology, 2015

Affinity capillary electrophoresis as a tool for optimizing topical drug formulations

– Journal of Pharmaceutical and Biomedical Analysis,2019

Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Prof. Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Researcher | University of Athens | Greece

Panagiotis Halvatsiotis is an Assistant Professor of Medicine with specialization in endocrinology and metabolic research, focusing on diabetes, obesity, insulin resistance, and metabolic regulation across clinical and molecular contexts. His research explores skeletal muscle metabolism, protein synthesis, adipokine signaling, and the metabolic impact of nutritional and pharmacological interventions, alongside emerging interests in population-based metabolic risk and COVID-19–related metabolic outcomes. He holds key academic and clinical research roles within university medical settings and has collaborated extensively in multidisciplinary, international research teams. Dr. Halvatsiotis has made significant contributions through high-impact studies elucidating insulin action, amino acid kinetics, and metabolic dysregulation in type 2 diabetes, as well as influential systematic reviews informing dietary and public health policy. His work has generated widely cited evidence shaping clinical practice guidelines. His impact vision centers on translating metabolic research into scalable interventions that improve chronic disease management, inform evidence-based nutrition strategies, and advance global metabolic health innovation.

Citation Metrics (Google Scholar)

1500

1000

600

0

Citations
1455

Documents
17

h-index
28

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar

Featured Publications

Meheli Ghosh | Dermatology | Research Excellence Award

Meheli Ghosh | Dermatology | Research Excellence Award

PHD | Mercer University | United States

Meheli Ghosh is a pharmaceutical sciences researcher specializing in advanced drug delivery systems and dermatological/transdermal formulation development. Her research focuses on topical and transdermal drug delivery, microneedle-based systems, nanoparticulate and microparticulate carriers, foam and gel formulations, and quality-by-design approaches for skin-targeted therapies, with emerging interests in regulatory-relevant bioequivalence and late-stage product development. She has gained significant research experience through collaborative projects with the U.S. Food and Drug Administration, NIH-funded programs, and industry-aligned research at Merck Group, contributing to formulation design, process optimization, IVRT/IVPT studies, and regulatory documentation. Her key contributions include the development of novel drug-loaded microneedles using vacuum compression molding, innovative nanoparticle- and emulsome-based systems for chemical injury mitigation, and advanced topical platforms addressing unmet dermatological needs. Impact Vision: Her work bridges academic research and regulatory science, accelerating the translation of safe, effective, and scalable dermatological therapies that advance global skin health and pharmaceutical innovation.

 

Citation Metrics (Google Scholar)

100

80

60

20

0

Citations
94

i10-index
4

h-index
4

🟦 Citations
🟥 i10-index
🟩 h-index


View Google Scholar

Featured Publications

 

Huei-Jane Lee | Skin Inflammation | Best Researcher Award

Prof. Huei-Jane Lee | Skin Inflammation | Best Researcher Award

Chung Shan Medical University | Taiwan

Dr. Huei-Jane Lee, a distinguished researcher at Chung Shan Medical University Hospital, Taichung, Taiwan, is widely recognized for her substantial contributions to clinical and biomedical research, supported by an extensive academic background in medical and health sciences. Over the course of her career, she has established expertise across a diverse range of research areas, including clinical diagnostics, disease epidemiology, medical imaging, oncology, and translational health sciences. Dr. Lee has authored 55 peer-reviewed publications, which have collectively garnered 1,531 citations across 1,421 documents, reflecting the strong global influence and relevance of her work, while her h-index of 23 demonstrates sustained scholarly impact. Her research portfolio includes collaborations with more than 140 co-authors, illustrating her active engagement in interdisciplinary teams and international scientific networks. Dr. Lee’s publication record highlights significant findings in patient care optimization, diagnostic innovation, and evidence-based medical practice, contributing directly to improved clinical outcomes and public health advancements. She has received recognition from academic and research institutions for her commitment to scientific excellence and her contributions to advancing medical knowledge. In addition to her research achievements, Dr. Lee has served in various roles supporting the academic community, including editorial or reviewer responsibilities for scientific journals, where she contributes to maintaining the rigor and quality of scholarly publications. Her ongoing work continues to bridge clinical practice with scientific discovery, demonstrating a strong commitment to advancing healthcare through research, fostering interdisciplinary collaboration, and contributing to the global scientific community.

Profiles: Scopus | ORCID

Featured Publications

1. Author, A. A., et al. (2025). Neurodevelopmental SHQ1 variants navigate the control of apoptosis, endoplasmic reticulum stress, and oxidative stress in neuroblastoma cells. Neuroscience.

2. Author, A. A., et al. (2025). Abelmoschus esculentus ameliorates cognitive impairment in hyperlipidemic ApoE−/− mice via modulation of oxidative stress and neuronal differentiation. Antioxidants.

3. Author, A. A., et al. (2025). Fermented strawberry (Fragaria × ananassa Duch.) mitigates renal fibrosis in a unilateral ureteral obstruction model by reducing inflammation, oxidative stress, and regulating Smad signaling. Journal of Medicinal Food.

4. Author, A. A., et al. (2025). Purple sweet potato ameliorates high-fat diet-induced visceral adiposity by attenuating inflammation and promoting adipocyte browning. Journal of Agricultural and Food Chemistry.

5. Author, A. A., et al. (2025). Apple polyphenol mitigates diabetic nephropathy via attenuating renal dysfunction with antioxidation in streptozotocin-induced diabetic rats. Antioxidants.